- Home
- TNGX vs NPCT Comparison
TNGX vs NPCT Comparison
Compare TNGX & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NPCT
- Stock Information
- Founded
- TNGX 2014
- NPCT 2020
- Country
- TNGX United States
- NPCT United States
- Employees
- TNGX N/A
- NPCT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- TNGX Health Care
- NPCT Finance
- Exchange
- TNGX Nasdaq
- NPCT Nasdaq
- Market Cap
- TNGX 317.4M
- NPCT 311.7M
- IPO Year
- TNGX N/A
- NPCT N/A
- Fundamental
- Price
- TNGX $1.72
- NPCT $10.66
- Analyst Decision
- TNGX Strong Buy
- NPCT
- Analyst Count
- TNGX 7
- NPCT 0
- Target Price
- TNGX $12.33
- NPCT N/A
- AVG Volume (30 Days)
- TNGX 801.9K
- NPCT 107.1K
- Earning Date
- TNGX 05-07-2025
- NPCT 01-01-0001
- Dividend Yield
- TNGX N/A
- NPCT 9.82%
- EPS Growth
- TNGX N/A
- NPCT N/A
- EPS
- TNGX N/A
- NPCT N/A
- Revenue
- TNGX $42,069,000.00
- NPCT N/A
- Revenue This Year
- TNGX N/A
- NPCT N/A
- Revenue Next Year
- TNGX N/A
- NPCT N/A
- P/E Ratio
- TNGX N/A
- NPCT N/A
- Revenue Growth
- TNGX 15.17
- NPCT N/A
- 52 Week Low
- TNGX $1.71
- NPCT $8.58
- 52 Week High
- TNGX $12.02
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- TNGX 33.42
- NPCT 39.59
- Support Level
- TNGX $1.68
- NPCT $10.64
- Resistance Level
- TNGX $2.04
- NPCT $10.72
- Average True Range (ATR)
- TNGX 0.17
- NPCT 0.10
- MACD
- TNGX 0.01
- NPCT -0.03
- Stochastic Oscillator
- TNGX 12.12
- NPCT 6.19
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.